Ethics Opinions

Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion (2023)

In some instances, it is ethically permissible for the physician to either disclose material information to the affected party or to decline to provide or continue to provide care.

Ethics Committee Document

Publication DateOctober 01, 2023

View the Report

Informed consent in assisted reproduction: an Ethics Committee opinion (2023)

Informed consent is a process in which the patient is supported in developing an understanding of medical options.

Ethics Committee Document

Publication DateJune 01, 2023

View the Report

Defining embryo donation: an Ethics Committee opinion (2023)

The ethical appropriateness of patients donating embryos to other patients for family building, or for research, is well established.

Ethics Committee Document

Publication DateJune 01, 2023

View the Report

Interests, obligations, and rights in gamete and embryo donation: an Ethics Committee opinion (2019)

This Ethics Committee report outlines the interests, obligations, and rights of all parties involved in gamete and embryo donation: both males and females who choose to provide gametes or embryos

Ethics Committee Document

Publication DateApril 01, 2023

View the Report

Consideration of the gestational carrier: an Ethics Committee opinion (2023)

Intended parents engage with gestational carriers (GCs) to achieve their personal reproductive goals.

Ethics Committee Document

Publication DateJanuary 10, 2023

View the Report

Updated terminology for gamete and embryo donors: directed (identiﬁed) to replace ‘‘known’’ and nonidentiﬁed to replace ‘‘anonymous’’: a committee opinion (2022)

The American Society for Reproductive Medicine encourages all stakeholders with an interest in gamete and embryo donation to adopt directed (identiﬁed) in lieu of ‘‘known’’ and nonidentiﬁed in

Ethics Committee Document

Publication DateAugust 17, 2022

View the Report

Human immunodeﬁciency virus and infertility treatment: an Ethics Committee opinion (2021)

Human Immunodeﬁciency Virus is a serious but manageable chronic disease that affects persons of reproductive age, many of whom express a desire for biological parenthood.

Ethics Committee Document

Publication DateApril 30, 2022

View the Report

Cross-border reproductive care: an Ethics Committee opinion (2022)

Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care, what harms and benefits may result, and

Ethics Committee Document

Publication DateFebruary 23, 2022

View the Report

Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)

Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. During such crises, physicians should ensure

Ethics Committee Document

Publication DateFebruary 09, 2022

View the Report

Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion (2022)

It is ethically appropriate for providers to treat women who are at elevated risk provided that the women are carefully assessed, that specialists in their medical condition are consulted as

Ethics Committee Document

Publication DateJanuary 31, 2022

View the Report

Ethics Committee Opinions